期刊文献+

肝细胞癌患者外周血中调节性T细胞、NK细胞及NKT细胞的表达及意义 被引量:10

Expression and significance of regulatory T cells,NK cells and NKT cells in peripheral venous blood of patients with hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨CD4+CD25+调节性T细胞、CD3-CD57+NK细胞及CD3+CD57+NKT细胞在肝细胞癌患者外周血中的表达及意义。方法利用流式细胞仪对31例肝细胞癌患者、59例慢性肝炎、肝硬化患者及48例正常人外周血中的CD4+CD25+调节性T细胞、CD3-CD57+NK细胞及CD3+CD57+NKT细胞进行定量分析。结果肝细胞癌组外周血中CD4+CD25+T细胞较正常对照组及慢性肝炎、肝硬化组明显减少(P<0.05),肝细胞癌组外周血中CD3-CD57+NK细胞及CD3+CD57+NKT细胞较正常对照组及慢性肝炎、肝硬化组明显增加(P<0.05)。结论 CD4+CD25+调节性T细胞可能通过对CD3-CD57+NK细胞及CD3+CD57+NKT细胞功能的抑制参与了肝癌细胞的免疫逃逸作用。 Objective To investigate the expression and significance of the alteration of CD4+CD25+ regulatory T cells,CD3^-CD57^+ NK cells and CD3^+CD57^+ NKT cells in peripheral venous blood in patients of hepatocellular carcinoma(HCC).Methods The number and distribution of CD4+CD25+ regulatory T cells,CD3^-CD57^+ NK cells and CD3^+CD57^+ NKT cells in peripheral venous blood(31 patients of HCC,59 patients of chronic hepatitis and hepatic cirrhosis vs 48 healthy control) were analyzed by flow cytometry.Results Compared with normal control and the group of chronic hepatitis and hepatic cirrhosis,CD4^+CD25^+ regulatory T cells were reduced significantly(P〈 0.05) in peripheral venous blood in patients of HCC,while,CD3^-CD57^+ NK cells and CD3^+CD57^+ NKT cells were increased significantly(P〈 0.05).Conclusion CD4^+CD25^+ regulatory T cells possibly participate in immune es-cape of hepatocellular carcinoma through inhibition of CD3^-CD57^+ NK cells and CD3^+CD57^+ NKT cells.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2010年第3期227-229,共3页 Journal of Harbin Medical University
基金 黑龙江省留学归国及海外学者合作基金项目(LC06C30) 黑龙江省教育厅科学技术研究面上项目(11531191)
关键词 CD4^+CD25^+调节性T细胞 肝细胞癌 CD3^-CD57^+NK细胞 CD3^+CD57^+NKT细胞 CD4^+CD25^+regulatory T cells hepatocellular carcinoma CD3^-CD57^+NK cells CD3^+CD57^+NKT cells
  • 相关文献

参考文献9

  • 1中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14009
  • 2高橘武司.CD4^+CD25^+T细胞の自己免疫反応抑制の機序.Annual Beview免疫,2000,4(4):312-319.
  • 3杨秀华,刘冰熔,姜洪池.肝细胞癌患者肝脏组织中CD4^+CD25^+调节性T淋巴细胞的表达及意义[J].中华肝脏病杂志,2007,15(4):279-282. 被引量:8
  • 4Dieckmann D,Plottner H,Berchtold S,et al.Ex vivo isolation and characterization of CD4^+CD25^+ T cells with regulatory properfies from human blood[J].J Exp Med,2001,193(11):1303-1310.
  • 5Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptorchains(CD25).Breackdown of single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol,1995,155(3):1151-1164.
  • 6Yang XH,yamagiwa S,Ichida T,et al.Increase of CD4+CD25+regulatory T-cells in the liver of patients with hepatocellular carcinoma[J].J Hepatol,2006,45(2):254-262.
  • 7Smyth MJ,Thia KY,Stret SE,et al.Differentuial tumor surveillance by natural killer(NK) and NKT cells[J].J Exp Med,2000,191(4):661-668.
  • 8Kim S,lizyka K,Aguila HL,et al.In vivo natural killer acivities revealed by natural killer cell-deficient mice[J].Proc Natl Acad Sci U S A,2000,97(6):2731-2736.
  • 9Trznkowski P,Szmit E,Mysliwska J,et al.CD4^+CD25^+ T regulatory cells inhibit cytotoxic activtiy of T CD8^+ and NK lymphocytes in the direct cell-to-cell interaction[J].Clin Immunol,2004,112(3):258-267.

二级参考文献13

  • 1Jones E, Dahm-Vicker M, Golgher D, et al. CD25(+) regulatory T cells and tumor immunity. Immunol Lett, 2003, 85: 141- 143.
  • 2Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299: 1057- 1061.
  • 3Woo EY, Chu CS, Goletz TJ, et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res, 2001, 61: 4766- 4772.
  • 4Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature, 1999, 401: 659-660.
  • 5Stephens LA, Mottet C, Mason D, et al. Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol, 2001, 31: 1247- 1254.
  • 6Ormandy LA, Hillemann T, Wedemeyer H, et al. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res, 2005, 65: 2457- 2464.
  • 7Bystry RS, Aluvihare V, Welch KA, et al. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol, 2001, 2: 1126-1132.
  • 8Dieckmann D, Plottner H, Berchtold S, et al. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med, 2001, 193: 1303- 1310.
  • 9Woo EY, Yeh H, Chu CS, et al. Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol, 2002, 168: 4272-4276.
  • 10Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res, 2003, 9: 606-612.

共引文献14014

同被引文献81

  • 1周健,牛新清,梅家转,王杨,涂三芳,何颖芝,周雪云,郭坤元.同种异体NK细胞对不同肿瘤细胞的体外杀伤活性及其机制的初步探讨[J].现代免疫学,2008,28(1):7-11. 被引量:5
  • 2李红兵,陈明.乙型肝炎慢性化细胞免疫机制研究进展[J].医学综述,2005,11(8):679-682. 被引量:9
  • 3谭进富,吕明德,刘大全,王竹,周忠信,黄洁夫.微波消融肝癌对小鼠细胞免疫的影响[J].中国病理生理杂志,2006,22(6):1214-1217. 被引量:10
  • 4杨秀华,刘冰熔,姜洪池.肝细胞癌患者肝脏组织中CD4^+CD25^+调节性T淋巴细胞的表达及意义[J].中华肝脏病杂志,2007,15(4):279-282. 被引量:8
  • 5Quintini C, Hirose K, Hashimoto K, et al. "Splenic artery steal syndrome" is a misnomer: the cause is portal hyperperfusion, not arterial siphon [ J ]. Liver Transpl,2008 ; 14 ( 3 ) :374-9.
  • 6Humar A, Beissel J, Crotteau S, et al. Delayed splenic artery occlusion for treatment of established small for-size syndrome after partial liver trans- plantation [J]. Liver Transpl, 2009 ; 15 ( 2 ) : 163-8.
  • 7Alkozai EM, Nijsten MW, de Jong KP, et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after par- tial liver resection[ J]. Ann Surg,2010;251 (2) :300-6.
  • 8Baik YH, An JY, Noh JH, et al. Can serum interleukin 2 receptor dpha predict lymph node metastasis in early gas tric cancer?[J].J Korean Surg Soc, 2012,82(3):143-148.
  • 9Eller T,Vasar V,Shlik J,et al. The role of IL-2 and solu ble IL-2R in depression and antidepressant response[J]. Curr Opin Investig Drugs,2009,10(7):638-643.
  • 10Kanda K, Komekado H, Sawabu T, et al. Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic eytokine signalling via enhanced ectodomain shedding of TNF alpha[J]. Embo Mol Med, 2012,4(5) :396 -411.

引证文献10

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部